Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Widmer

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Compendium of Continuing Education in Dentistry (Jamesburg, N.J. : 1995)|February 7, 2007
Enamel acid etching: a reviewGuilherme Carpena Lopes, Daniela Greenhalgh Thys, Priscila Klaus, et al.
Blood|September 3, 2010
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinibAmina Haouala, Nicolas Widmer, Michel A Duchosal, et al.
European Journal of Internal Medicine|November 29, 2016
Transition of care: A set of pharmaceutical interventions improves hospital discharge prescriptions from an internal medicine wardMarine Neeman, Maria Dobrinas, Sophie Maurer, et al.
BMC Health Services Research|July 2, 2022
Full-scale simulations to improve disaster preparedness in hospital pharmaciesLaurence Schumacher, Salim Senhaji, Birgit Andrea Gartner, et al.
Trials|July 18, 2016
Biases affecting injected doses of an experimental drug during clinical trialsNancy Perrottet, Françoise Brunner-Ferber, Eric Grouzmann, et al.
Frontiers in Pharmacology|March 21, 2020
The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With ImatinibThierry Buclin, Yann Thoma, Nicolas Widmer, et al.
European Journal of Hospital Pharmacy : Science and Practice|April 9, 2021
Using risk analysis to ensure patients' medication safety during hospital relocations and evacuationsLaurence Schumacher, Florian Berthaudin, Anne-Laure Blanc, et al.
Drug Metabolism Letters|May 8, 2010
siRNA-mediated knock-down of P-glycoprotein expression reveals distinct cellular disposition of anticancer tyrosine kinases inhibitorsAmina Haouala, Holger Rumpold, Gerold Untergasser, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2014
Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapiesNicolas Widmer, Christophe Bardin, Etienne Chatelut, et al.
Drugs - Real World Outcomes|December 31, 2021
Pharmaceutical Interventions on Hospital Discharge Prescriptions: Prospective Observational Study Highlighting Challenges for Community PharmacistsSophie Grandchamp, Anne-Laure Blanc, Marine Roussel, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Compendium of Continuing Education in Dentistry (Jamesburg, N.J. : 1995)|February 7, 2007
Enamel acid etching: a reviewGuilherme Carpena Lopes, Daniela Greenhalgh Thys, Priscila Klaus, et al.
Blood|September 3, 2010
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinibAmina Haouala, Nicolas Widmer, Michel A Duchosal, et al.
European Journal of Internal Medicine|November 29, 2016
Transition of care: A set of pharmaceutical interventions improves hospital discharge prescriptions from an internal medicine wardMarine Neeman, Maria Dobrinas, Sophie Maurer, et al.
BMC Health Services Research|July 2, 2022
Full-scale simulations to improve disaster preparedness in hospital pharmaciesLaurence Schumacher, Salim Senhaji, Birgit Andrea Gartner, et al.
Trials|July 18, 2016
Biases affecting injected doses of an experimental drug during clinical trialsNancy Perrottet, Françoise Brunner-Ferber, Eric Grouzmann, et al.
Frontiers in Pharmacology|March 21, 2020
The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With ImatinibThierry Buclin, Yann Thoma, Nicolas Widmer, et al.
European Journal of Hospital Pharmacy : Science and Practice|April 9, 2021
Using risk analysis to ensure patients' medication safety during hospital relocations and evacuationsLaurence Schumacher, Florian Berthaudin, Anne-Laure Blanc, et al.
Drug Metabolism Letters|May 8, 2010
siRNA-mediated knock-down of P-glycoprotein expression reveals distinct cellular disposition of anticancer tyrosine kinases inhibitorsAmina Haouala, Holger Rumpold, Gerold Untergasser, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2014
Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapiesNicolas Widmer, Christophe Bardin, Etienne Chatelut, et al.
Drugs - Real World Outcomes|December 31, 2021
Pharmaceutical Interventions on Hospital Discharge Prescriptions: Prospective Observational Study Highlighting Challenges for Community PharmacistsSophie Grandchamp, Anne-Laure Blanc, Marine Roussel, et al.
Pageof 6